KRAVIS HENRY R
SEC CIK 1081714 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KKR | KKR & Co. | Executive Co-COB, Dir, 10% | 5.46M | — | $537.63M | 13 | 2021-11-03 | 2025-11-12 |
| BTSG | BrightSpring Health Services, Inc. | 10% | 0 | — | $424.36M | 3 | 2025-10-22 | 2025-10-22 |
| BBIO | BridgeBio Pharma, Inc. | 10% | 13.26M | — | $205.20M | 1 | 2025-05-12 | 2025-05-12 |
| APP | AppLovin | 10% | 761.1K | — | $2.00B | 7 | 2023-08-14 | 2024-11-21 |
| COTY | COTY INC. | 10% | 50.00M | — | — | 1 | 2021-09-07 | 2021-09-07 |
Most active insiders at KKR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | NUTTALL SCOTT C | Co-CEO, Dir | $17.22M | — |
| 2 | BAE JOSEPH Y | Co-CEO, Dir | $17.20M | — |
| 3 | BARAKETT TIMOTHY R | Dir | $9.97M | — |
| 4 | Cohler Matt | Dir | $4.51M | — |
| 5 | Dillon Mary N | Dir | $2.02M | — |
| 6 | HOLMES DANE E | Chief Administrative Off | — | $1.09M |
| 7 | Gutierrez Arturo | Dir | — | — |
| 8 | Lewin Robert H | CFO | — | — |
| 9 | NIEL XAVIER BRUNO | Dir | — | — |
| 10 | Spiegel Evan | Dir | — | — |
| 15 | KRAVIS HENRY R | Co-Executive COB, Dir | — | — |
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-11-14 | 2025-11-12 | KKR | KKR & Co. | KRAVIS HENRY R | Co-Executive COB, Dir | G - Gift | $0.00 | -350.0K | 5.46M | -6% | $0 |
| MI | 2025-10-22 | 2025-10-22 | BTSG | BrightSpring Health Services, Inc. | KRAVIS HENRY R | 10% | G - Gift | $0.00 | -90.0K | 0 | -100% | $0 |
| I | 2025-10-22 | 2025-10-22 | BTSG | BrightSpring Health Services, Inc. | KRAVIS HENRY R | 10% | J - Other | $0.00 | -409.3K | 61.94M | -0.7% | $0 |
| I | 2025-10-22 | 2025-10-22 | BTSG | BrightSpring Health Services, Inc. | KRAVIS HENRY R | 10% | S - Sale | $28.78 | -14.74M | 62.35M | -19% | -$424.36M |
| 2025-06-02 | 2025-06-02 | KKR | KKR & Co. | KRAVIS HENRY R | Co-Executive COB, Dir | S - Sale | $119.80 | -1.15M | 73.01M | -2% | -$137.83M | |
| I | 2025-06-02 | 2025-06-02 | KKR | KKR & Co. | KRAVIS HENRY R | Co-Executive COB, Dir | S - Sale | $121.67 | -130.9K | 0 | -100% | -$15.93M |
| I | 2025-05-16 | 2025-05-15 | KKR | KKR & Co. | KRAVIS HENRY R | Co-Executive COB, Dir | J - Other | — | -250.4K | 1.55M | -14% | — |
| I | 2025-05-14 | 2025-05-12 | BBIO | BridgeBio Pharma, Inc. | KRAVIS HENRY R | 10% | S - Sale | $34.20 | -6.00M | 13.26M | -31% | -$205.20M |
| I | 2025-03-14 | 2025-03-13 | KKR | KKR & Co. | KRAVIS HENRY R | Co-Executive COB, Dir | G - Gift | $0.00 | -208.7K | 0 | -100% | $0 |
| DMI | 2024-11-25 | 2024-11-21 | APP | AppLovin | KRAVIS HENRY R | 10% | S - Sale | $309.97 | -5.27M | 761.1K | -87% | -$1.63B |
| DI | 2024-11-25 | 2024-11-21 | APP | AppLovin | KRAVIS HENRY R | 10% | C - Cnv Deriv | — | +5.21M | 5.34M | +3,805% | — |
| DMI | 2024-11-25 | 2024-11-21 | APP | AppLovin | KRAVIS HENRY R | 10% | G - Gift | $0.00 | -17.1K | 0 | -100% | $0 |
| DI | 2024-11-25 | 2024-11-21 | APP | AppLovin | KRAVIS HENRY R | 10% | J - Other | $0.00 | -68.0K | 0 | -100% | $0 |
| I | 2024-03-08 | 2024-03-06 | KKR | KKR & Co. | KRAVIS HENRY R | Co-Executive COB, Dir | G - Gift | $0.00 | -500.0K | 5.81M | -8% | $0 |
| I | 2023-08-16 | 2023-08-14 | APP | AppLovin | KRAVIS HENRY R | 10% | J - Other | $0.00 | -74.6K | 19.57M | -0.4% | $0 |
| I | 2023-08-16 | 2023-08-14 | APP | AppLovin | KRAVIS HENRY R | 10% | G - Gift | $0.00 | -4,052 | 0 | -100% | $0 |
| I | 2023-08-16 | 2023-08-14 | APP | AppLovin | KRAVIS HENRY R | 10% | S - Sale | $37.00 | -10.00M | 19.64M | -34% | -$370.00M |
| D | 2022-05-31 | 2022-05-27 | KKR | KKR & Co. | KRAVIS HENRY R | Co-Executive COB, Dir | J - Other | — | +1,338 | 1.15M | +0.1% | — |
| D | 2022-05-31 | 2022-05-31 | KKR | KKR & Co. | KRAVIS HENRY R | Co-Executive COB, Dir | M - OptEx | — | +71.85M | 73.00M | +6,245% | — |
| DI | 2022-05-31 | 2022-05-13 | KKR | KKR & Co. | KRAVIS HENRY R | Co-Executive COB, Dir | G - Gift | $0.00 | -340.0K | 6.31M | -5% | $0 |
| DI | 2022-05-31 | 2022-05-31 | KKR | KKR & Co. | KRAVIS HENRY R | Co-Executive COB, Dir | M - OptEx | — | +1.50M | 1.50M | New | — |
| DI | 2022-05-31 | 2022-05-31 | KKR | KKR & Co. | KRAVIS HENRY R | Co-Executive COB, Dir | A - Grant | — | +49.4K | 1.55M | +3% | — |
| D | 2022-05-31 | 2022-05-31 | KKR | KKR & Co. | KRAVIS HENRY R | Co-Executive COB, Dir | A - Grant | — | +2.36M | 75.37M | +3% | — |
| I | 2021-11-05 | 2021-11-03 | KKR | KKR & Co. | KRAVIS HENRY R | Executive Co-COB, Dir, 10% | S - Sale | $82.25 | -4.67M | 0 | -100% | -$383.87M |
| DI | 2021-09-09 | 2021-09-07 | COTY | COTY INC. | KRAVIS HENRY R | 10% | C - Cnv Deriv | $6.24 | +50.00M | 50.00M | New | +$312.00M |
Purchase Sale Sale after option exercise All abbreviations